{"id":"https://openalex.org/W2913110725","doi":"https://doi.org/10.1182/blood-2018-175","title":"Biomarkers Predicting Venetoclax Sensitivity and Strategies for Venetoclax Combination Treatment","display_name":"Biomarkers Predicting Venetoclax Sensitivity and Strategies for Venetoclax Combination Treatment","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2913110725","doi":"https://doi.org/10.1182/blood-2018-175","mag":"2913110725"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-175","doi":"https://doi.org/10.1182/blood-2018-175","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-175","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101415354","display_name":"Haijiao Zhang","orcid":"https://orcid.org/0000-0002-0749-9866","observed_orcids":["https://orcid.org/0000-0002-0749-9866"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haijiao Zhang","raw_affiliation_strings":["Knight Cancer Institute, Oregon Health & Science Univerisity, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health & Science Univerisity, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010834454","display_name":"Beth Wilmot","orcid":"https://orcid.org/0000-0003-3579-3592","observed_orcids":["https://orcid.org/0000-0003-3579-3592"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Beth Wilmot","raw_affiliation_strings":["Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061516412","display_name":"Daniel Bottomly","orcid":"https://orcid.org/0000-0001-7191-0990","observed_orcids":["https://orcid.org/0000-0001-7191-0990"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Bottomly","raw_affiliation_strings":["Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075070858","display_name":"Stephen E. Kurtz","orcid":"https://orcid.org/0000-0003-4762-389X","observed_orcids":["https://orcid.org/0000-0003-4762-389X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen E Kurtz","raw_affiliation_strings":["Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030828526","display_name":"Christopher A. Eide","orcid":"https://orcid.org/0000-0001-8835-8928","observed_orcids":["https://orcid.org/0000-0001-8835-8928"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher A. Eide","raw_affiliation_strings":["Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040407244","display_name":"Alisa Damnernsawad","orcid":"https://orcid.org/0000-0001-7565-076X","observed_orcids":["https://orcid.org/0000-0001-7565-076X"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alisa Damnernsawad","raw_affiliation_strings":["Knight Cancer Institute, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068111916","display_name":"Kyle Alexander Romine","orcid":"https://orcid.org/0000-0003-3757-7690","observed_orcids":["https://orcid.org/0000-0003-3757-7690"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kyle Romine","raw_affiliation_strings":["Knight Cancer Institute, Oregon Health & Science Univeristy,, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health & Science Univeristy,, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040438640","display_name":"Shyam Ajay Patel","orcid":"https://orcid.org/0000-0002-8208-1902","observed_orcids":["https://orcid.org/0000-0002-8208-1902","https://orcid.org/0000-0001-5856-9062"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shyam Patel","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["Howard Hughes Medical Institute, Portland, OR","Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute, Portland, OR","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079500498","display_name":"Schannon K Mcweeney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Schannon K Mcweeney","raw_affiliation_strings":["Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science Univeristy, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Bioinformatics and Computational Biology, Oregon Health & Science Univeristy, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074919402","display_name":"Ravindra Majeti","orcid":"https://orcid.org/0000-0002-5814-0984","observed_orcids":["https://orcid.org/0000-0002-5814-0984"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Majeti","raw_affiliation_strings":["Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Tyner","raw_affiliation_strings":["Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5010834454","https://openalex.org/A5030828526","https://openalex.org/A5040407244","https://openalex.org/A5040438640","https://openalex.org/A5061516412","https://openalex.org/A5068111916","https://openalex.org/A5075070858","https://openalex.org/A5079500498"],"corresponding_institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4210137306","https://openalex.org/I4390039369","https://openalex.org/I97018004"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"175","last_page":"175"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.7950000166893005},{"id":"https://openalex.org/keywords/drug-sensitivity-biomarkers","display_name":"drug sensitivity biomarkers","score":0.8069999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7509999871253967},{"id":"https://openalex.org/keywords/bcl2a1","display_name":"BCL2A1","score":0.9369999766349792},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/dectin-1","display_name":"Dectin-1","score":0.7599999904632568},{"id":"https://openalex.org/keywords/cd14","display_name":"CD14","score":0.9599999785423279},{"id":"https://openalex.org/keywords/gene-expression-clusters","display_name":"gene expression clusters","score":0.6340000033378601},{"id":"https://openalex.org/keywords/drug-combination-therapy","display_name":"drug combination therapy","score":0.453000009059906},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.7590000033378601},{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.640999972820282},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9859435558319092},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5337650775909424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.503835141658783},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.49110865592956543},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47379323840141296},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42408376932144165},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.42321544885635376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41053149104118347},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3668016791343689},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3429202437400818},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2490537464618683},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.24173054099082947},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.1267499029636383},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12663793563842773},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12404215335845947},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0898047685623169}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-175","doi":"https://doi.org/10.1182/blood-2018-175","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-175","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3069119239","https://openalex.org/W4285733393","https://openalex.org/W2991545584","https://openalex.org/W3047980356","https://openalex.org/W4310107706","https://openalex.org/W2502304077","https://openalex.org/W2908596525","https://openalex.org/W4417069311","https://openalex.org/W2504352323","https://openalex.org/W2987207927"],"abstract_inverted_index":{"Abstract":[0],"BCL2":[1,30,220,241,249],"is":[2,14,26,87,246],"an":[3,45,590,614,638,654,667,691,705,724,743,757,772,787,805],"antiapoptotic":[4],"protein":[5],"commonly":[6],"expressed":[7],"in":[8,19,37,52,57,76,104,138,163,206,554],"hematologic":[9],"malignancies.":[10],"Overexpression":[11],"of":[12,83,152,354,468,581,593,617,641,657,670,694,708,727,746,760,775,790,808],"BCL-2":[13],"a":[15,27,307,426,480,505,568],"poor":[16],"prognostic":[17],"factor":[18],"acute":[20],"myeloid":[21],"leukemia":[22,39],"(AML).":[23],"Venetoclax":[24],"(ABT-199)":[25],"highly":[28],"selective":[29],"inhibitor":[31,460],"that":[32,186,271,321,423,431,448,494,521,541],"can":[33],"induce":[34],"cell":[35,40,272,375],"death":[36],"multiple":[38],"lines.":[41],"Recently,":[42],"venetoclax":[43,69,100,110,160,187,223,261,281,299,311,361,415,418,498,525,552,561,569],"received":[44],"FDA":[46],"breakthrough":[47],"therapy":[48],"designation":[49],"for":[50,65],"use":[51],"combination":[53,111],"with":[54,60,137,155,165,189,209,227,240,260,280,330,340,405,475,489,500,515,530,567],"hypomethylating":[55],"agents":[56],"treatment-na\u00efve":[58],"patients":[59,529,566],"AML":[61,78,121,153,287,322,374,469],"who":[62],"are":[63,333,347,432,444,449,495],"unfit":[64],"intensive":[66],"chemotherapy.":[67],"However,":[68],"was":[70,397],"only":[71,248],"modestly":[72],"effective":[73],"as":[74,306,479,548],"monotherapy":[75],"relapsed/refractory":[77],"(19%":[79],"CR/CRi).":[80],"The":[81],"aim":[82],"the":[84,146,219,247,258,265,352,458,466,476,485],"current":[85],"study":[86],"to":[88,95,98,107,149,159,309,336,394,400,434,451,497,527,550,559,564],"integrate":[89],"genomic":[90],"and":[91,102,106,124,132,162,179,198,215,231,256,277,284,317,328,338,344,357,388,442,471,499,517,556,562],"functional":[92],"screen":[93],"data":[94,136,142],"identify":[96,108,150,310],"biomarkers":[97,549],"predict":[99,551],"sensitivity":[101,156,282,300,362,553],"resistance":[103,158,526],"AML,":[105,207,555],"potential":[109,454,506],"treatment":[112],"strategies.":[113],"In":[114,536],"this":[115],"study,":[116],"we":[117,184,269,319,421,538,557],"investigated":[118],"approximately":[119],"200":[120],"patient":[122,288],"samples":[123,154,289,323,339,430,447,470,493],"correlated":[125,188,226,239,257,279,514],"clinical":[126],"parameters,":[127],"whole":[128],"exome":[129],"sequence":[130],"data,":[131],"RNAseq":[133],"gene":[134,182,191,203,221,251,267],"expression":[135,192,204,478,574],"vitro":[139],"drug":[140,365,419],"screening":[141],"(drug":[143],"area":[144],"under":[145],"curve":[147],"(AUC))":[148],"subsets":[151],"or":[157,575,579,595,619,643,659,672,696,710,729,748,762,777,792,810],"alone":[161],"combinations":[164],"10":[166],"small":[167],"molecular":[168],"inhibitors":[169],"(Array-382,":[170],"dasatinib,":[171],"JQ-1,":[172],"idelalisib,":[173],"quizartinib,":[174],"palbociclib,":[175],"panobinostat,":[176],"ruxolitinib,":[177],"sorafenib,":[178],"trametinib).":[180],"For":[181,314,417],"expression,":[183,235,387,411,503,519,578],"observed":[185,270,320,422],"3":[190],"clusters":[193,205,255],"(coefficient":[194],"frequency:":[195],"0.94,":[196],"0.80":[197],"0.71":[199],"respectively)":[200],"among":[201],"21":[202],"associated":[208],"innate":[210],"immune":[211],"system,":[212],"neutrophil":[213],"degranulation,":[214],"interleukin-10":[216],"signaling.":[217],"Among":[218],"family,":[222],"AUC":[224,511],"positively":[225],"BCL2A1":[228,245,410,477,502,577],"(r=0.59,":[229],"p<0.0001)":[230,243],"MCL1":[232,386,402],"(r=0.26,":[233],"p=0.001)":[234],"whereas":[236,436],"it":[237],"negatively":[238,513],"(r=-0.53,":[242],"expression.":[244,403,535],"family":[250],"within":[252,264],"all":[253],"three":[254,266],"best":[259],"sensitivity.":[262],"Interestingly,":[263,457],"clusters,":[268],"surface":[273],"markers":[274],"CLEC7A":[275,516,532,544],"(CD369)":[276],"CD14":[278,291,518,534,542],"(r=0.68":[283],"0.64,":[285],"p<0.0001).":[286],"expressing":[290],"detected":[292],"by":[293,363],"flow":[294],"cytometry":[295],"also":[296,512],"demonstrated":[297,384,408,425,462],"reduced":[298],"(p=0.005),":[301],"which":[302,396,412],"could":[303,523,545],"potentially":[304,413],"serve":[305],"biomarker":[308],"resistant":[312,450,496,570],"patients.":[313],"cytogenetic":[315],"categories":[316],"mutations,":[318],"harboring":[324,381],"PML-RARA":[325],"translocations,":[326],"WT1,":[327,355],"FLT3":[329],"IDH1":[331],"mutations":[332,346,359,383,407],"more":[334,348],"sensitive":[335,393,433],"venetoclax,":[337,435,452,490],"TET2,":[341],"KRAS,":[342,356],"PTPN11":[343,358,382,389],"SF3B1":[345],"resistant.":[349],"We":[350],"validated":[351],"effect":[353,428,464],"on":[360,367,429,465,492,589,613,637,653,666,690,704,723,742,756,771,786,804],"performing":[364],"assays":[366],"mouse":[368],"bone":[369],"marrow":[370],"stem":[371],"cells":[372,391],"and/or":[373,533,543],"lines":[376],"overexpressing":[377],"each":[378],"mutant.":[379],"Samples":[380,404],"high":[385,409,501,531,576],"mutant-transduced":[390],"remain":[392],"Idasanutlin,":[395],"previously":[398],"shown":[399],"downregulate":[401],"KRAS":[406,582],"mediate":[414],"resistance.":[416],"combinations,":[420],"venetoclax-trametinib":[424],"synergistic":[427],"venetoclax-palbociclib,":[437],"venetoclax-Array-382,":[438],"venetoclax-sorafenib,":[439],"venetoclax-ruxolitinib,":[440],"venetoclax-dasatinib,":[441],"venetoclax-idelalisib":[443],"active":[445],"against":[446],"indicating":[453,504,520],"therapeutic":[455],"combinations.":[456],"CDK":[459],"palbociclib":[461,563],"no":[463],"majority":[467],"does":[472],"not":[473],"correlate":[474],"single":[481],"agent,":[482],"yet":[483],"shows":[484],"most":[486],"robust":[487],"synergy":[488],"especially":[491],"synthetic":[507],"lethal":[508],"interaction.":[509],"Venetoclax-palbociclib":[510],"venetoclax-palbociclib":[522],"circumvent":[524],"treat":[528,565],"summary,":[537],"have":[539],"identified":[540],"be":[546],"used":[547],"propose":[558],"combine":[560],"profile":[571],"(high":[572],"CD14/CLEC7A":[573],"presence":[580],"mutations).":[583],"Disclosures":[584],"Druker:":[585],"Beta":[586],"Cat:":[587],"Membership":[588,612,636,652,665,689,703,722,741,755,770,785,803],"entity's":[591,615,639,655,668,692,706,725,744,758,773,788,806],"Board":[592,616,640,656,669,693,707,726,745,759,774,789,807],"Directors":[594,618,642,658,671,695,709,728,747,761,776,791,809],"advisory":[596,620,644,660,673,697,711,730,749,763,778,793,811],"committees;":[597,621,645,661,674,712,731,750,764,779],"Fred":[598],"Hutchinson":[599],"Cancer":[600],"Research":[601,603,632,647,679,699,814,817,820,823,831,834,837,840,843,846],"Center:":[602],"Funding;":[604,633,648,680,700,815,818,821,824,832,835,838,841,844],"McGraw":[605],"Hill:":[606],"Patents":[607,627,682,735],"&":[608,624,628,683,686,736],"Royalties;":[609,629,684,737],"Vivid":[610],"Biosciences:":[611],"Oregon":[622],"Health":[623],"Science":[625],"University:":[626],"Bristol-Meyers":[630],"Squibb:":[631],"GRAIL:":[634],"Consultancy,":[635,664,702,721,752,767,782,800],"ARIAD:":[646],"Third":[649],"Coast":[650],"Therapeutics:":[651,714,781],"Gilead":[662],"Sciences:":[663],"Monojul:":[675],"Consultancy;":[676,715,719,739,796],"Novartis":[677],"Pharmaceuticals:":[678],"Millipore:":[681],"Leukemia":[685],"Lymphoma":[687],"Society:":[688],"committees,":[698],"ALLCRON:":[701],"Aileron":[713],"Patient":[716],"True":[717],"Talk:":[718],"Cepheid:":[720],"Henry":[732],"Stewart":[733],"Talks:":[734],"Celgene:":[738],"Amgen:":[740],"MolecularMD:":[751],"Equity":[753,768,783,801,827],"Ownership,":[754,769,784,802],"Blueprint":[765],"Medicines:":[766],"Aptose":[780],"committees.":[794,812],"Majeti:BioMarin:":[795],"Forty":[797],"Seven,":[798],"Inc:":[799],"Tyner:Incyte:":[813],"AstraZeneca:":[816],"Janssen:":[819],"Takeda:":[822],"Leap":[825],"Oncology:":[826],"Ownership;":[828],"Seattle":[829],"Genetics:":[830],"Genentech:":[833],"Gilead:":[836],"Syros:":[839],"Aptose:":[842],"Agios:":[845],"Funding.":[847]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}